← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 15, 2018Last known activity
Jul 25, 2025
Timeline
2010s
- Jun 1, 2016
TransThera Biosciences Co., Ltd— Founded
Drugs by trial phase (9 distinct, 16 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06370013Lead sponsorN/A—
- NCT07052253CollaboratorPhase 2Jul 25, 2025
- NCT05948475Lead sponsorPhase 3Dec 31, 2023
- NCT06057571Lead sponsorPhase 2Nov 7, 2023
- NCT05683717Lead sponsorPhase 1Mar 30, 2023
- NCT05673538Lead sponsorPhase 1Jan 31, 2023
- NCT05275504Lead sponsorPhase 1Jun 30, 2022
- NCT05253053Lead sponsorPhase 1/Phase 2Apr 13, 2022
- NCT05355129Lead sponsorPhase 1Nov 3, 2021
- NCT04919642Lead sponsorPhase 2Oct 31, 2021
- NCT05043792Lead sponsorPhase 1Sep 20, 2021
- NCT04742959Lead sponsorPhase 1/Phase 2Jul 14, 2021
- NCT04830501Lead sponsorPhase 1Jul 12, 2021
- NCT04705922Lead sponsorPhase 1Dec 29, 2020
- NCT04364789Lead sponsorPhase 1Feb 5, 2020
Details
- Founded
- Nanjing, CN Jun 1, 2016
- Last known activity
- Jul 25, 2025